Mycobacterium kansasii and human immunodeficiency virus co-infection in London

Journal of Infection

Volumn 37, Issue 3, 1998, Pages 252-259

  Klein, J L ^a,c   Corbett, E L ^b   Slade, P M ^a   Miller, R F ^b   Coker, R J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ISONIAZID;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CITY; CLINICAL ARTICLE; ENDEMIC DISEASE; FECES ANALYSIS; GASTROINTESTINAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; RELAPSE; RETROSPECTIVE STUDY; UNITED KINGDOM; UNITED STATES;

EID: 0032441388     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)92014-X     Document Type: Article

References (25)

1. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax 1983; 38: 271-274.
2. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982; 146: 829-833.
3. Lamden K, Waton JM, Knerer G, Ryan MJ, Jenkins PA. Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev 1996; 6: 147-151.
4. Marks K. "Opportunist" Mycobacteria in England and Wales. Tubercle 1969; 50 (Suppl.): 78-80.
5. Bamberger DM, Driks MR, Gupta MR et al. Mycobacterium kansasii among patients infected with Human Immunodeficiency Virus in Kansas City. Clin Infect Dis 1994; 18: 395-400.
6. Parenti DM, Symington JS, Keiser J, Simon GL. Mycobacterium kansasii bacteraemia in patients infected with Human Immunodeficiency Virus. Clin Infect Dis 1995; 21: 1001-1003.
7. Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis 1988; 137: 1217-1222.
8. Horsburgh CR, Selik RM. The epidemiology of disseminated non-tuberculous mycobacterial infection in the Acquired Immunodeficiency Syndrome (AIDS). Am Rev Respir Dis 1989; 139: 4-7.
9. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for Human Immunodeficiency Virus. Rev Infect Dis 1990; 13: 789-796.
10. Valainis GT, Cardona LM, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J AIDS 1991; 4: 516-520.
11. Witzig RS, Fazal BA, Mera RM et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and Human Immunodeficiency Virus Type 1. Clin Infect Dis 1995; 21: 77-85.
12. Wallace RJ, Glassroth J, Griffith DE, Olivier KN, Cook JL, Gordin F. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
13. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced Human Immunodeficiency Virus (HIV) infection. Ann Intern Med 1991; 114: 861-868.
14. Rooney G, Nelson MR, Gazzard B. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. J Clin Pathol 1996; 49: 821-823.
15. Centers For Disease Control. Diagnosis and management of mycobacterial disease in persons with Human Immunodeficiency Virus infection. Ann Intern Med 1987; 106: 254-256.
16. Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994; 49: 442-445.
17. Jacobs MR. Activity of quinolones against mycobacteria. Drugs 1995; 49 (Suppl. 2): 67-75.
18. Sherer R, Sable R, Sonnenberg M et al. Disseminated infection with Mycobacterium kansasii in the Acquired Immunodeficiency Syndrome. Ann Intern Med 1986: 105: 710-712.
19. Chin DP. Hopewell PC, Yajko DM et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with Human Immunodeficiency Virus infection. J Infect Dis 1994; 169: 289-295.
20. Joynson DHM. Water: the natural habitat of Mycobacterium kansasii? Tubercle 1979; 60: 77-81.
21. Brammer DW, O'Rourke CM, Heath LA, Chrisp CE, Peter GK, Hofing GL. Mycobacterium kansasii infection in squirrel monkeys (Saimiri sciureus). J Med Primatol 1995; 24: 231-235.
22. Ross BC, Jackson K, Yang M, Sievers A, Dwyer B. Identification of a genetically distinct subspecies of Mycobacterium kansasii. J Clin Microbiol 1992; 30: 2930-2933.
23. 3 Alcaide F, Richter I, Bernasconi C et al. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 1997; 35: 1959-1964.
24. Tortoli E, Simonetti MT, Lacchini C, Penati V, Urbano P. Tentative evidence of AIDS-associated biotype of Mycobacterium kansasii. J Clin Microbiol 1994; 32: 1779-1782.
25. Picardeau M, Prod'hom G, Raskine L, LePennec MP, Vincent V. Genotypic characterisation of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997; 35: 25-32.